Aspect Biosystems

Aspect Biosystems Ltd. is an award winning Canadian startup developing state-of-the-art 3D bioprinting technology capable of creating living human tissues on demand. Aspect aims to drive a fundamental shift in the pharmaceutical industry by enabling the development of physiologically relevant human tissue models for pre-clinical drug testing, moving away from the use of animals and de-risking customers’ drug assets entering clinical trials. Aspect is a forward-looking company, and envisions a future where our technology is used directly to save lives through the creation of personalized implantable tissue, and even functional organs.